US FDA Approves Novo Nordisk's Ozempic to Cut Risk of Diabetic Kidney Disease Progression
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney disease (CKD),
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,
The Food & Drug Administration (FDA), has quietly taken down their guidance detailing diversity action plans for clinical ...
3don MSN
The U.S. Food and Drug Administration wants to put nutrition information front and center on food products to give consumers ...
Trump's FDA moved to squash a proposed rule to ban menthol cigarettes just one day after the president was sworn in, angering ...
The Health and Human Services Office of Inspector General has found that, in a few cases, FDA officials veered from the accelerated approval pathway.
RFK Jr. said in Wednesday's confirmation hearing that he wants to combat food dyes. 'Crunchy moms' finally feel seen.
44mon MSN
Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation ...
Aaron Siri, a lawyer advising Robert F. Kennedy Jr. as he prepared to become health secretary, petitioned the Food and Drug ...
Follow live updates and news coverage of the Senate confirmation hearing for RFK Jr. Stay up to date with real-time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback